LonapegsomatropinGH BoosterSafety Rating 8/10
Primary research areaPediatric growth hormone deficiency
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range0.24 mg/kg weekly
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Skytrofa)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Lonapegsomatropin
Mechanism of action
PEGylated recombinant GH prodrug; weekly dosing
Safety profile
Injection site reactions, arthralgia, glucose intolerance · Approved pediatric GH deficiency; weekly dosing; similar safety to daily somatropin
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Lonapegsomatropin below your target.
Related pages